Vaccine Pioneer Albert Bourla Donates $1M Prize To Greek Holocaust Museum
Albert Bourla, the Pfizer CEO behind the lifesaving COVID vaccine, received the $1m Genesis Prize from Israeli President Isaac Herzog on Wednesday. Dr Bourla, 60, said he was donating the entire sum towards establishing a holocaust museum in Greece, where his parents were among the 2,000 Jews from Thessaloniki who survived. The Genesis Prize is […]
June 30, 2022
Pfizer Extends Partnership With Israeli Drug Development Firm CytoReason
CytoReason built a machine learning platform that can quantify a person’s immune system in order to better understand disease responses.
February 15, 2022
Women Report Twice As Many Side Effects As Men After COVID-19 Vaccine, Israeli Study Shows
Researchers from the University of Haifa said that women reported 1.9 times as many side effects as men after receiving the Pfizer vaccine.
February 10, 2022
Pfizer Chief Albert Bourla Wins Genesis Prize, Donates $1M To Holocaust Projects
Genesis Prize Foundation recognized Bourla for leading Pfizer's efforts to develop the COVID-19 vaccine and his willingness to take risks.
January 19, 2022
Biotech Innovation Lab Harnesses Power Of AI For Drug Development In Israel
AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science
October 17, 2021
US Looks To Israeli Military Data To Weigh Safety Of Booster Shots
Top US health official Dr. Anthony Fauci says Israel to soon have more information on myocarditis, an inflammation of the heart in younger males.
October 03, 2021
Israel’s CytoReason Launches AI Drug Discovery Platform In Japanese Market
Israeli AI company Cytoreason develops computational disease models of the human immune system for discovery and clinical drug development.
September 30, 2021
Vaccinated Nursing Moms Produce COVID-19 Antibodies In Breastmilk – Israeli Study
Early research shows the vaccine triggers an antibody response in breastmilk, potentially contributing to the protection of breastfed babies.
March 10, 2021
Pfizer, AstraZeneca Selected To Establish New Innovation Lab
The innovation lab, which will also include pharma companies Merck, and Teva, will research digital health and computational biology.
December 30, 2020
Israeli Biotech Startup Combines Immunology, AI To Help Develop Better Drugs
Founded in 2016, CytoReason already has partnerships with top global pharmaceutical companies.
May 14, 2019
Data-Powered Drug Discovery Startup CytoReason Signs Deal With Pfizer
The company's propriety platform combines scientific and experimental data for immune system simulations applicable to cancer immunotherapy, and autoimmune, neurodegenerative and infectious disease research.
January 08, 2019
Drug Sealer DIR Raises $10M From Pfizer
December 28, 2016 | DIR Technologies, which is developing quality control devices for the pharmaceutical industry, will receive a $10 million investment from pharmaceutical giant Pfizer under a strategic cooperation agreement. DIR’s products inform users whether a small bottle or package of drugs is properly sealed when it leaves the factory. The usual method of […]
December 28, 2016
Viagra Slows Blood Flow In Brain Of Stroke Victims, Study Shows
Israeli research showing that Pfizer’s blockbuster erectile-function medication Viagra can cause risky side effects in men who have had a stroke have induced Wolfson Medical Center researchers to determine whether the competing drug, GlaxoSmithKline’s Cialis, has the same effect.
September 27, 2011